Clinical Research
person

Roxana S.

Country
Romania
Department
Medical Oncology

Research Overview

assignment
17
Clinical Trials ·
location_city
1
Research Sites

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
279
Sites with multiple studies

Has run more than one trial at 279 of 569 partner sites.

Specializations

Non-Small Cell Lung Cancer and Molecularly Defined Lung Tumors

Roxana Scheusan is actively involved in clinical research for advanced and metastatic non-small cell lung cancer, with strong interest in biomarker-selected populations such as KRAS G12C-mutant disease, EGFR exon 20 insertion tumors, uncommon EGFR mutations, HER2-altered disease, and c-Met-overexpressing NSCLC. Her trial portfolio also includes resectable, unresectable, and perioperative lung cancer settings.

  • Advanced and metastatic NSCLC
  • KRAS G12C, EGFR, HER2, and c-Met-driven lung cancer
  • Resectable and unresectable thoracic malignancies

Her work reflects a focus on targeted and immunotherapy-based treatment strategies in lung cancer across locally advanced, recurrent, and metastatic disease states.

Immuno-Oncology and Checkpoint-Based Therapy

She is engaged in studies centered on immune checkpoint inhibitors and combination immunotherapy in melanoma, NSCLC, and other solid tumors. This includes research involving PD-L1-selected populations, adjuvant and first-line settings, and regimens combining immunotherapy with chemotherapy or other novel agents.

  • PD-L1-selected solid tumors
  • Melanoma and lung cancer immunotherapy
  • Combination checkpoint inhibitor strategies

Her clinical interests extend to treatment approaches designed to improve disease control in both early and advanced malignancies through immune-based therapy.

Small Cell Lung Cancer and Thoracic Malignancies

Her research landscape includes small cell lung cancer, particularly relapsed and extensive-stage disease, as well as broader thoracic oncology topics such as locally advanced unresectable disease and post-chemoradiation treatment. She is also involved in studies addressing squamous cell carcinoma of the head and neck within the thoracic and upper aerodigestive tumor spectrum.

  • Extensive-stage small cell lung cancer
  • Relapsed thoracic malignancies
  • Head and neck squamous cell carcinoma

Her portfolio shows sustained involvement in cancers with limited treatment options, especially where novel systemic therapies are being explored.

Breast, Endometrial, and Ovarian Cancer

Roxana Scheusan also contributes to research in gynecologic and breast oncology, including early breast cancer, endometrial cancer, ovarian neoplasms, fallopian tube neoplasms, and peritoneal neoplasms. These studies address both hormone receptor-directed treatment and advanced platinum-sensitive or platinum-resistant disease.

  • Early breast cancer
  • Endometrial cancer
  • Ovarian, fallopian tube, and peritoneal malignancies

Her involvement spans recurrence prevention, endocrine therapy, and treatment options for advanced gynecologic cancers.

Solid Tumors, Melanoma, and Cancer-Related Complications

Her clinical trial activity includes broader solid tumor research, unresectable or metastatic melanoma, and supportive oncology topics such as cancer-associated thrombosis. She is also involved in studies across recurrent or metastatic disease settings where new systemic options are being evaluated.

  • Unresectable or metastatic melanoma
  • Advanced solid tumors
  • Cancer-associated thrombosis

Her research interests cover both tumor-directed therapy and complications arising during cancer treatment.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.